Skip to main content
Erschienen in: Annals of Surgical Oncology 1/2024

08.11.2023 | Reconstructive Oncology

Establishment and Feasibility of an Immediate Lymphatic Reconstruction Program in a Community Health System

verfasst von: Pranav N. Haravu, BS, Afaaf Shakir, MD, Katherine Jackson, OTR/L, CLT-LANA, Duanny Alva, MPH, Joseph Feldman, MD, Mark Sisco, MD, FACS, Akhil K. Seth, MD, FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Breast cancer-related lymphedema (BCRL) remains a significant post-surgical complication of breast cancer treatment. Immediate lymphatic reconstruction (ILR) at the time of axillary lymph node dissection (ALND) has shown promise in preventing BCRL. While the primary literature supporting ILR comes from academic institutions, the majority of breast cancer care in the USA occurs in the community setting. This study evaluated a preventative lymphedema program performing ILR at a community health system.

Patients and Methods

A prospective database including all patients who underwent ALND with concurrently attempted ILR from 2019 to 2021 was retrospectively reviewed. The historical benchmark lymphedema rate was calculated through retrospective review of electronic medical records for all patients who underwent ALND without ILR from 2011 to 2021.

Results

Ninety patients underwent ALND with ILR, of which ILR was successful in 69 (76.7%). ILR was more likely to be aborted in smokers (p < 0.05) and those with fewer lymphatic channels (p < 0.05) or a higher body mass index (BMI) (p = 0.08). Patients with successful versus aborted ILR had lower lymphedema rates (10.9% versus 66.7%, p < 0.01) and improved Disability of the Arm, Shoulder, and Hand (DASH) scores (8.7 versus 19.8, p = 0.25), and lower lymphedema rates than the historical benchmark (10.9% versus 50.2%, p < 0.01). Among patients with successful ILR, older patients were more likely to develop lymphedema (p < 0.05).

Conclusions

Successful ILR after ALND significantly reduced the lymphedema rate when compared with patients with aborted ILR and our institution’s historical benchmark. Our experience supports the efficacy of ILR and highlights the feasibility of ILR within a community health system.
Literatur
3.
Zurück zum Zitat Boccardo F, Casabona F, DeCian F, et al. Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: Over 4 years follow-up. Microsurgery. 2014;34(6):421–4.CrossRefPubMed Boccardo F, Casabona F, DeCian F, et al. Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: Over 4 years follow-up. Microsurgery. 2014;34(6):421–4.CrossRefPubMed
4.
Zurück zum Zitat Golshan M, Martin WJ, Dowlatshahi K. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg. 2003;69(3):209–11.CrossRefPubMed Golshan M, Martin WJ, Dowlatshahi K. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg. 2003;69(3):209–11.CrossRefPubMed
5.
Zurück zum Zitat DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15.CrossRefPubMed DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15.CrossRefPubMed
6.
Zurück zum Zitat Rebegea L, Firescu D, Dumitru M, et al. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer. Chir Buchar Rom. 2015;110(1):33–7. Rebegea L, Firescu D, Dumitru M, et al. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer. Chir Buchar Rom. 2015;110(1):33–7.
7.
Zurück zum Zitat McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213–9.CrossRefPubMedPubMedCentral McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213–9.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Gillespie TC, Sayegh HE, Brunelle CL, et al. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg. 2018;7(4):379–403.CrossRefPubMedPubMedCentral Gillespie TC, Sayegh HE, Brunelle CL, et al. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg. 2018;7(4):379–403.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Warren LEG, Miller CL, Horick N, et al. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol. 2014;88(3):565–71.CrossRef Warren LEG, Miller CL, Horick N, et al. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol. 2014;88(3):565–71.CrossRef
10.
Zurück zum Zitat Fu MR, Axelrod D, Guth AA, et al. Patterns of obesity and lymph fluid level during the first year of breast cancer treatment: a prospective study. J Pers Med. 2015;5(3):326–40.CrossRefPubMedPubMedCentral Fu MR, Axelrod D, Guth AA, et al. Patterns of obesity and lymph fluid level during the first year of breast cancer treatment: a prospective study. J Pers Med. 2015;5(3):326–40.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Jammallo LS, Miller CL, Singer M, et al. Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat. 2013;142(1):59–67.CrossRefPubMed Jammallo LS, Miller CL, Singer M, et al. Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat. 2013;142(1):59–67.CrossRefPubMed
12.
Zurück zum Zitat Sosin M, Yin C, Poysophon P, Patel KM. Understanding the concepts and physiologic principles of lymphatic microsurgery. J Reconstr Microsurg. 2016;32(8):571–9.CrossRefPubMed Sosin M, Yin C, Poysophon P, Patel KM. Understanding the concepts and physiologic principles of lymphatic microsurgery. J Reconstr Microsurg. 2016;32(8):571–9.CrossRefPubMed
14.
Zurück zum Zitat Fu MR, Ridner SH, Hu SH, et al. Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psychooncology. 2013;22:1466–84.CrossRefPubMed Fu MR, Ridner SH, Hu SH, et al. Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psychooncology. 2013;22:1466–84.CrossRefPubMed
15.
Zurück zum Zitat Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol. 2012;30:3726–33.CrossRefPubMed Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol. 2012;30:3726–33.CrossRefPubMed
16.
Zurück zum Zitat Johnson AR, Singhal D. Immediate lymphatic reconstruction. J Surg Oncol. 2018;118(5):750–7.CrossRefPubMed Johnson AR, Singhal D. Immediate lymphatic reconstruction. J Surg Oncol. 2018;118(5):750–7.CrossRefPubMed
17.
Zurück zum Zitat Basta MN, Gao LL, Wu LC. Operative treatment of peripheral lymphedema: a systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation. Plast Reconstr Surg. 2014;133(4):905–13.CrossRefPubMed Basta MN, Gao LL, Wu LC. Operative treatment of peripheral lymphedema: a systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation. Plast Reconstr Surg. 2014;133(4):905–13.CrossRefPubMed
18.
Zurück zum Zitat Pusic AL, Cemal Y, Albornoz C, et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv Res Pract. 2013;7(1):83–92.CrossRef Pusic AL, Cemal Y, Albornoz C, et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv Res Pract. 2013;7(1):83–92.CrossRef
19.
Zurück zum Zitat Chang DW, Dayan J, Greene AK, et al. Surgical treatment of lymphedema: a systematic review and meta-analysis of controlled trials. Results of a consensus conference. Plast Reconstr Surg. 2021;147(4):975–93.CrossRefPubMed Chang DW, Dayan J, Greene AK, et al. Surgical treatment of lymphedema: a systematic review and meta-analysis of controlled trials. Results of a consensus conference. Plast Reconstr Surg. 2021;147(4):975–93.CrossRefPubMed
22.
Zurück zum Zitat Johnson AR, Kimball S, Epstein S, et al. Lymphedema incidence after axillary lymph node dissection: quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach. Ann Plast Surg. 2019;82(4S):S234–41.CrossRefPubMed Johnson AR, Kimball S, Epstein S, et al. Lymphedema incidence after axillary lymph node dissection: quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach. Ann Plast Surg. 2019;82(4S):S234–41.CrossRefPubMed
23.
Zurück zum Zitat Hahamoff M, Gupta N, Munoz D, et al. A lymphedema surveillance program for breast cancer patients reveals the promise of surgical prevention. J Surg Res. 2019;244:604–11.CrossRefPubMed Hahamoff M, Gupta N, Munoz D, et al. A lymphedema surveillance program for breast cancer patients reveals the promise of surgical prevention. J Surg Res. 2019;244:604–11.CrossRefPubMed
25.
Zurück zum Zitat Johnson AR, Asban A, Granoff MD, et al. Is immediate lymphatic reconstruction cost-effective? Ann Surg. 2021;274(6):e581–8.CrossRefPubMed Johnson AR, Asban A, Granoff MD, et al. Is immediate lymphatic reconstruction cost-effective? Ann Surg. 2021;274(6):e581–8.CrossRefPubMed
26.
Zurück zum Zitat Copur MS, Ramaekers R, Gulzow M, et al. ReCAP: Impact of the national cancer institute community cancer centers program on clinical trial and related activities at a community cancer center in rural Nebraska. J Oncol Pract. 2016;12:67–8.CrossRefPubMed Copur MS, Ramaekers R, Gulzow M, et al. ReCAP: Impact of the national cancer institute community cancer centers program on clinical trial and related activities at a community cancer center in rural Nebraska. J Oncol Pract. 2016;12:67–8.CrossRefPubMed
27.
Zurück zum Zitat Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: The DASH (Disabilities of the Arm, Shoulder and Hand). The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996;29(6):602–8.CrossRefPubMed Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: The DASH (Disabilities of the Arm, Shoulder and Hand). The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996;29(6):602–8.CrossRefPubMed
28.
Zurück zum Zitat Ancukiewicz M, Russell TA, Otoole J, et al. Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys. 2011;79(5):1436–43.CrossRefPubMed Ancukiewicz M, Russell TA, Otoole J, et al. Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys. 2011;79(5):1436–43.CrossRefPubMed
29.
Zurück zum Zitat Johnson AR, Fleishman A, Granoff MD, et al. Evaluating the impact of immediate lymphatic reconstruction for the surgical prevention of lymphedema. Plast Reconstr Surg. 2021;147(3):373e–81e.CrossRefPubMed Johnson AR, Fleishman A, Granoff MD, et al. Evaluating the impact of immediate lymphatic reconstruction for the surgical prevention of lymphedema. Plast Reconstr Surg. 2021;147(3):373e–81e.CrossRefPubMed
32.
Zurück zum Zitat Levy AS, Murphy AI, Ishtihar S, et al. Lymphatic microsurgical preventive Healing approach for the primary prevention of lymphedema: a 4-year follow-up. Plast Reconstr Surg. 2023;151(2):413–20.CrossRefPubMed Levy AS, Murphy AI, Ishtihar S, et al. Lymphatic microsurgical preventive Healing approach for the primary prevention of lymphedema: a 4-year follow-up. Plast Reconstr Surg. 2023;151(2):413–20.CrossRefPubMed
33.
Zurück zum Zitat Chun MJ, Saeg F, Meade A, et al. Immediate lymphatic reconstruction for prevention of secondary lymphedema: a meta-analysis. J Plast Reconstr Aesthet Surg. 2022;75(3):1130–41.CrossRefPubMed Chun MJ, Saeg F, Meade A, et al. Immediate lymphatic reconstruction for prevention of secondary lymphedema: a meta-analysis. J Plast Reconstr Aesthet Surg. 2022;75(3):1130–41.CrossRefPubMed
34.
Zurück zum Zitat Johnson AR, Fleishman A, Tran BNN, et al. Developing a lymphatic surgery program: a first-year review. Plast Reconstr Surg. 2019;144(6):975e–85e.CrossRefPubMed Johnson AR, Fleishman A, Tran BNN, et al. Developing a lymphatic surgery program: a first-year review. Plast Reconstr Surg. 2019;144(6):975e–85e.CrossRefPubMed
35.
Zurück zum Zitat Deban M, McKinnon JG, Temple-Oberle C. Mitigating breast-cancer-related lymphedema-A Calgary program for immediate lymphatic reconstruction (ILR). Curr Oncol. 2023;30(2):1546–59.CrossRefPubMedPubMedCentral Deban M, McKinnon JG, Temple-Oberle C. Mitigating breast-cancer-related lymphedema-A Calgary program for immediate lymphatic reconstruction (ILR). Curr Oncol. 2023;30(2):1546–59.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Davies C, Brockopp D, Moe K. Test-retest and internal consistency of the Disability of Arm, Shoulder and Hand (DASH) outcome measure in assessing functional status among breast cancer survivors with lymphedema. Rehab Oncol. 2015;33(1):28–31. Davies C, Brockopp D, Moe K. Test-retest and internal consistency of the Disability of Arm, Shoulder and Hand (DASH) outcome measure in assessing functional status among breast cancer survivors with lymphedema. Rehab Oncol. 2015;33(1):28–31.
Metadaten
Titel
Establishment and Feasibility of an Immediate Lymphatic Reconstruction Program in a Community Health System
verfasst von
Pranav N. Haravu, BS
Afaaf Shakir, MD
Katherine Jackson, OTR/L, CLT-LANA
Duanny Alva, MPH
Joseph Feldman, MD
Mark Sisco, MD, FACS
Akhil K. Seth, MD, FACS
Publikationsdatum
08.11.2023
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 1/2024
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-023-14521-0

Weitere Artikel der Ausgabe 1/2024

Annals of Surgical Oncology 1/2024 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.